Faegre Drinker represented Brickell Biotech, Inc., a clinical-stage pharmaceutical company, in a $20 million offering consisting of common stock and warrants.
Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.
.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
